111153-74-3 Usage
Description
1-Phenylpiperidine-4-carbaldehyde is an organic compound with the molecular formula C16H15NO. It is a derivative of piperidine, featuring a phenyl group and a formyl group attached to its structure. 1-PHENYLPIPERIDINE-4-CARBALDEHYDE is known for its potential applications in the pharmaceutical and chemical industries due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
1-Phenylpiperidine-4-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its ability to form derivatives with potential therapeutic properties makes it a valuable building block in drug development.
Used in the Preparation of Cardiotonic Agents:
1-Phenylpiperidine-4-carbaldehyde is used as a reagent for the preparation of 2-phenylthiazolidine derivatives, which are known to have cardiotonic properties. These derivatives can be employed as active ingredients in the development of medications aimed at improving heart function and treating various cardiovascular conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 111153-74-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,1,5 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 111153-74:
(8*1)+(7*1)+(6*1)+(5*1)+(4*5)+(3*3)+(2*7)+(1*4)=73
73 % 10 = 3
So 111153-74-3 is a valid CAS Registry Number.
111153-74-3Relevant articles and documents
NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF
-
Paragraph 00392, (2020/12/01)
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
AMINE COMPOUNDS
-
Page 227-228, (2010/02/07)
The present invention provide a compound of the formula:wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.